In addition, the results of our protein phosphorylation studies indicated that the presence of triptolide reduced cisplatin-induced CHK1 phosphorylation at Ser317/345 but increased cisplatin-induced ATM phosphorylation at Ser1981 in both A549 and HTB182 lung cancer cells. This evidence concerns the gene CHEK1 and lung carcinoma.